Maryse J. Luijendijk

Maryse J. Luijendijk

Auto-generated profile, based on publicly available information

Maryse J. Luijendijk

Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Neuropsychology
Verified
Journal Article
Closed access
MLMaryse J. Luijendijk
Maryse J. Luijendijk
HFHeleen E. M. Feenstra
Heleen E. M. Feenstra
IVIvar E. Vermeulen
Ivar E. Vermeulen
JMJaap Murre
Jaap Murre
SSSanne B. Schagen
Sanne B. Schagen
Objective: Neuropsychological literature reports varying prevalence of cognitive impairment within patient populations, despite assessment with standardized neuropsychological tests. Within the domain of oncology, the International Cognition and Cancer Task Force (ICCTF) proposed standard cutoff points to harmonize the operationalization of cognitive impairment. We evaluated how this binary classification affects agreement between two highly comparable test batteries. Method: Two hundred non-central nervous system (non-CNS) cancer patients who finished treatment (56% females; median age 53 yrs) completed traditional tests and their online equivalents in a counterbalanced design. Following ICCTF standards, impairment was defined as a score of >= 1.5 standard deviations (SDs) below normative means on two tests and/or >= 2 SDs below normative means on one test. Agreement of classification between traditional and online assessment was evaluated using Cohen's kappa. Additional Monte Carlo simulations were conducted to demonstrate how different cutoff points and test characteristics affect agreement. Results: The correlation between total scores of traditional and online assessment was .78. Proportions of impaired patients did not differ between assessment methods: 40% using traditional tests and 38% using online equivalents, chi(2)(1) = .17, p < .68. Nevertheless, within-person agreement in impairment classification between traditional and online assessment was merely fair (K = .35). Monte Carlo simulations showed similarly low agreement scores (K = .41 for 1.5 SD; K = .33 for 2 SD criterion). Conclusions: Our results show that binary classification can lead to a situation where two highly similar batteries fail to identify the same individuals as impaired. Additional simulations suggest that within-person agreement between assessment methods using binary classification is inherently low. Modern statistical tools may help to improve validity of impairment detection.

26 November 2024 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MLMaryse J. Luijendijk
Maryse J. Luijendijk
SBSanne M. Buijs
Sanne M. Buijs
AJAgnes Jager
Agnes Jager
SKStijn L. W. Koolen
Stijn L. W. Koolen
EWElsken van der Wall
Elsken van der Wall
RMRon Mathijssen
Ron Mathijssen


10 December 2025 in Cancer
Verified
Journal Article
Closed access
MLMaryse J. Luijendijk
Maryse J. Luijendijk
PKPhilippe R. Lee Meeuw Kjoe
Philippe R. Lee Meeuw Kjoe
NWNoor Wortelboer
Noor Wortelboer
AOAnnemiek van Ommen‐Nijhof
Annemiek van Ommen‐Nijhof
ALA. Elise van Leeuwen‐Stok
A. Elise van Leeuwen‐Stok
SSSanne B. Schagen
Sanne B. Schagen

21 May 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
MLMaryse J. Luijendijk
Maryse J. Luijendijk
MTMargot E. T. Tesselaar
Margot E. T. Tesselaar
HRHuub H. van Rossum
Huub H. van Rossum
MFMartijn van Faassen
Martijn van Faassen
CKCatharina M. Korse
Catharina M. Korse
FVFroukje E. de Vries
Froukje E. de Vries
Cognitive and psychiatric problems are common in cancer patients, but literature on patients with neuroendocrine tumors (NET) is scarce. In a subset of these patients, the tumor produces serotonin, causing physical symptoms known as carcinoid syndrome. This peripheral overproduction of serotonin may cause central depletion of its precursor tryptophan, potentially resulting in cognitive and psychiatric problems. Therefore, we investigated cognitive and psychiatric function in patients with a serotonin overproduction and the association with this serotonin overproduction. Eighty-one patients with a serotonin-producing metastatic ileal NET underwent standardized neuropsychological and psychiatric assessment. Blood and urine samples were collected to determine concentrations of serotonin, its precursor tryptophan, and metabolite (5-HIAA). Multivariate normative comparison was applied to determine the prevalence of cognitive impairment. Separate linear regressions of serotonin, tryptophan, and 5-HIAA concentrations on cognitive function, depressive symptoms, and anxiety symptoms were performed, corrected for age, sex, education, and/or duration of illness. We found an 11% prevalence of cognitive impairment and a 20% prevalence of psychiatric disorders. Cognitive function was not related to measures of peripheral serotonin production. Unexpectedly, depressive symptoms were significantly associated with lower serum serotonin concentrations and elevated serum tryptophan concentrations. Cognitive symptoms of anxiety were also associated with elevated tryptophan concentrations. Concluding, cognitive or psychiatric problems occur in a minority of patients with NET and cannot be explained by tryptophan depletion following tumor-related serotonin production.

5 May 2026 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
MLMaryse J. Luijendijk
Maryse J. Luijendijk
EAElaine A. C. Albers
Elaine A. C. Albers
MEMees Egeler
Mees Egeler
LPLonneke V. van de Poll-Franse
Lonneke V. van de Poll-Franse
CBChristian U. Blank
Christian U. Blank
SSSanne B. Schagen
Sanne B. Schagen